Understanding how the immune system protects against respiratory viruses.
Mechanisms of Immune Protection Against Respiratory Viruses
This study is looking at how vaccines help our immune system fight off respiratory viruses and how long that protection lasts, and it's for people who want to understand more about how their bodies respond to vaccines and infections.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10824574 on NIH RePORTER |
What this research studies
This research investigates the immune responses to respiratory viruses, particularly focusing on how vaccines can generate long-lasting protection. It aims to define the mechanisms that allow the immune system to maintain effective responses after vaccination, including the role of specific immune cells like B cells and T cells. The study will involve human participants to assess how well their immune systems respond to vaccines and infections, providing insights that could lead to improved vaccine designs.
Who could benefit from this research
Good fit: Ideal candidates for participation are adults aged 21 and older who are interested in contributing to vaccine research and have not previously been vaccinated against the targeted respiratory viruses.
Not a fit: Patients who are under 21 years old or those with compromised immune systems may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective vaccines that provide long-lasting immunity against respiratory viruses.
How similar studies have performed: Previous research has shown promising results in understanding immune responses to vaccines, indicating that this approach has the potential for significant advancements.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Ellebedy, Ali Hassan — Washington University
- Study coordinator: Ellebedy, Ali Hassan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.